NCT06551129View on ClinicalTrials.gov

Real-world Patient Reported Outcomes Among Patients Treated With Camzyos

RecruitingOBSERVATIONAL
Enrollment

118

Participants

Timeline

Start Date

May 10, 2024

Primary Completion Date

December 31, 2026

Study Completion Date

June 30, 2027

Conditions
Obstructive Hypertrophic Cardiomyopathy
Interventions
DRUG

Mavacamten

As prescribed by treating physician

Trial Locations (1)

02199

RECRUITING

Analysis Group Inc., Boston

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY